Anti-IL1RAP/CD3 Bispecific Antibody (BsAb) Is a Promising Novel and Effective Therapy for Acute Myeloid Leukemia (AML)

被引：0
|
作者：
Meng, Weixu
Del Real, Marissa
Wei, Guowei
Hernandez, Rochelle
Marcucci, Emanuela
Lin, Allen
Mcdonald, Tinisha
Zhao, Dandan
Wu, Herman
Carlesso, Nadia
Kwak, Larry W.
Li, Ling
Kuo, Ya-Huei
Stein, Anthony S.
Pullarkat, Vinod
Nakamura, Ryotaro
Rosen, Steven T.
Forman, Stephen J.
Zhang, Bin
Budde, Lihua
Marcucci, Guido
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1361
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The Myeloid Cell Surface Receptor IREM-1: A Novel Monoclonal Antibody Target for Acute Myeloid Leukemia (AML)
    Zhao, Xiaoxian
    Korver, Wouter
    Singh, Shweta
    Pardoux, Cecile
    Hsi, Eric D.
    Abo, Arie
    BLOOD, 2008, 112 (11) : 1009 - 1009
  • [32] A Novel Anti-EGFR/CD3 Bispecific Antibody Exhibits Potent Efficacy for Osimertinib-resistant NSCLC
    Guo, H.
    Zhou, F.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S110 - S110
  • [33] EFFICACY OF ANTI-CD19 CAR T THERAPY AFTER BISPECIFIC MONOCLONAL ANTIBODY (CD19/CD3) THERAPY IN A PATIENT WITH RELAPSED Ph-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH A MASSIVE EXTRAMEDULLARY COMPONENT
    Aleshina, Olga A.
    Akezheva, Karina A.
    Eroshenkov, Daniil Yu.
    Vasilyeva, Anastasia N.
    Shchekina, Antonina E.
    Nalbandyan, Siranush A.
    Galstyan, Gennadiy M.
    Bogolyubova, Apollinariya, V
    Galtseva, Irina, V
    Kovrigina, Alla M.
    Parovichnikova, Elena N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2024, 69 (04): : 474 - 483
  • [34] A Novel Lair-1 Antibody Selectively Targets Acute Myeloid Leukemia (AML) Stem Cells
    Tian, Linjie
    Paucarmayta, Ana
    Lovewell, Rustin
    Maloveste, Karla
    Hong, Junshik
    Hedgepath, Carly
    Kim, Kwang Woon
    Copeland, Ron
    O'Neill, Thomas
    Patel, Shashank
    Liu, Linda N.
    Myint, Han
    Langermann, Solomon
    Flies, Dallas B.
    Kim, Tae Kon
    BLOOD, 2021, 138
  • [35] Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody
    Lopez-Albaitero, Andres
    Xu, Hong
    Guo, Hongfen
    Wang, Linlin
    Wu, Zhihao
    Tran, Hoa
    Chandarlapaty, Sarat
    Scaltriti, Maurizio
    Janjigian, Yelena
    de Stanchina, Elisa
    Cheung, Nai-Kong V.
    ONCOIMMUNOLOGY, 2017, 6 (03):
  • [36] Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of XmAb14045, a CD123 x CD3 T Cell-Engaging Bispecific Antibody: Initial Results of a Phase 1 Study
    Ravandi, Farhad
    Bashey, Asad
    Foran, James M.
    Stock, Wendy
    Mawad, Raya
    Blum, William
    Saville, M. Wayne
    Johnson, Chelsea M.
    Vanasse, K. Gary J.
    Ly, Thomas
    Kantarjian, Hagop M.
    Bhatnagar, Bhavana
    Takahashi, Koichi
    Mims, Alice S.
    BLOOD, 2018, 132
  • [37] COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia
    Kristina Klupsch
    Vanessa Baeriswyl
    Roland Scholz
    Joana Dannenberg
    Roger Santimaria
    David Senn
    Elena Kage
    Adrian Zumsteg
    Isabella Attinger-Toller
    Ulrike von der Bey
    Susann König-Friedrich
    Fanny Dupuy
    Wibke Lembke
    Clara Albani
    Severin Wendelspiess
    Lucijana Dinkel
    Dorina Saro
    Robert W. Hepler
    George S. Laszlo
    Chelsea J. Gudgeon
    Julian Bertschinger
    Simon Brack
    Roland B. Walter
    Leukemia, 2019, 33 : 805 - 808
  • [38] COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia
    Klupsch, Kristina
    Baeriswyl, Vanessa
    Scholz, Roland
    Dannenberg, Joana
    Santimaria, Roger
    Senn, David
    Kage, Elena
    Zumsteg, Adrian
    Attinger-Toller, Isabella
    von der Bey, Ulrike
    Konig-Friedrich, Susann
    Dupuy, Fanny
    Lembke, Wibke
    Albani, Clara
    Wendelspiess, Severin
    Dinkel, Lucijana
    Saro, Dorina
    Hepler, Robert W.
    Laszlo, George S.
    Gudgeon, Chelsea J.
    Bertschinger, Julian
    Brack, Simon
    Walter, Roland B.
    LEUKEMIA, 2019, 33 (03) : 805 - 808
  • [39] COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia
    Klupsch, Kristina
    Baeriswyl, Vanessa
    Scholz, Roland
    Dannenberg, Joana
    Santimaria, Roger
    Senn, David
    Kage, Elena
    Zumsteg, Adrian
    Attinger-Toller, Isabella
    von der Bey, Ulrike
    Konig-Friedrich, Susann
    Dupuy, Fanny
    Lembke, Wibke
    Albani, Clara
    Wendelspiess, Severin
    Dinkel, Lucijana
    Gudgeon, Chelsea J.
    Walter, Roland B.
    Bertschinger, Julian
    Brack, Simon
    CANCER RESEARCH, 2018, 78 (13)
  • [40] Induction of anti-tumor immunity by concomitant cell therapy and trifunctional bispecific antibody anti-(CD3 x Anti-EpCAM)
    Slavin, Shimon
    Lindhofer, Horst
    Yacovlev, Elena
    Gelfand, Yael
    Morecki, Shoshana
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 676 - 676
12345